Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Genetic Technologies ( (AU:GTG) ) is now available.
Genetic Technologies Limited announced the cessation of John Polinelli as a director, effective May 14, 2025. This update, provided under the ASX listing rule 3.19A.3, indicates no relevant interests in securities held by the departing director, suggesting minimal immediate impact on the company’s operations or market positioning.
More about Genetic Technologies
Genetic Technologies Limited is a company operating in the biotechnology industry, focusing on genetic testing and diagnostics. The company is known for its innovative genetic analysis services, catering to a diverse market that includes healthcare providers and individuals seeking personalized genetic information.
Technical Sentiment Signal: Sell
Current Market Cap: A$9.45M
See more insights into GTG stock on TipRanks’ Stock Analysis page.